LEARN MORE

Annual Meeting & Pre-Conference Programs

Biomarkers Workshop

The SITC Immune Biomarkers Oversight Committee reconvened for a two-day workshop in 2016 and 2018 to discuss critical next steps in the field, including obtaining and handling biospecimens, exploring, identifying and validating new biomarkers, data and specimen sharing and collaborating with other disciplines.

Cancer immune Responsiveness Workshop

Cancer Immune Responsiveness Task force hosted a two-day workshop in 2018 and 2019 which focused on the advancement of interactions between the immune system and cancer that contribute to immunotherapy response and resistance.

SITC Cancer Immunotherapy Winter School

The Cancer Immunotherapy Winter School curriculum covers the fundamentals of cancer immunotherapy.

2020 Cancer Immunotherapy Winter School 

• Immunotherapeutic Strategy: Immune Checkpoint Blockade

ACCESS ALL 2020 program MATERIALS HERE

Journal for Immunotherapy of Cancer

The Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.

Access 2020 Articles

• JITC Collection: “Immune Checkpoints Beyond PD-1”
• Original Research: “Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis"
• Original Research: “Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions"
• Original Research: Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

Top Accessed 2019 Articles

• Research Article: Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
• Short Report: Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience 
• Research Article: A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 
• Research Article: Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
• Research Article: α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas

ACCESS THE FULL JOURNAL

SITC Consensus Statements, Guidelines and White Papers

• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
• An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

• SITC Clinical Practice Guideline Webinar – Immune Checkpoint Inhibitor-related Adverse Events: August 13, 2021, 10 AM - 11 AM ET
• SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events: September 16, 2021, 11:30 AM - 12:30 PM ET
• SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events: October 6, 2021, 7 PM - 8 PM ET

• Cancer immunotherapy trials: leading a paradigm shift in drug development
• Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Textbook

Cancer Immunotherapy Principles and Practice is an authoritative textbook to cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. This comprehensive reference work covers all major topics that have shaped the development of immunotherapy and propelled it to its current place at the forefront of cancer treatment innovation.

Section 1: Basic Principles of Tumor Immunology

• Chapter 7: Regulation of Cell-Mediated Immunity: The Biology of Checkpoints and Regulatory T Cells

Section 2: Cancer Immunotherapy Targets and Classes

• Chapter 16: Manipulating Innate Immune Pathways as Cancer Immunotherapy
• Chapter 20: Immunotherapy Based on Blocking T Cell Inhibitory Pathways
• Chapter 24: Principles of Combination Immunotherapies

Section 3: Immune Function in Cancer

• Chapter 36: Tumor Microenvironment Metabolism as a Primordial Checkpoint in Antitumor T Cell Immunity

Section 4: Disease Specific Treatment and Outcomes

• Chapter 39: General Approach to Cancer Immunotherapy: Lessons Learned from the Past Years
• Chapter 40: Immunotherapy for Melanoma
• Chapter 41: Other Cutaneous Tumors: Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and Merkel Cell Carcinoma
• Chapter 42: Immunotherapy in Genitourinary Malignancies
• Chapter 43: Immunotherapy in Gastrointestinal Cancers
• Chapter 44: Immunotherapy of Hepatocellular Carcinoma
• Chapter 45: Immunotherapy for Gynecologic Malignancies
• Chapter 46: Breast Cancer Immunotherapy
• Chapter 47: Lung Cancer
• Chapter 48: Head and Neck Cancer
• Chapter 49: Immunotherapy for Hematologic Malignancies
• Chapter 50: Brain Tumors
• Chapter 51: Sarcomas
• Chapter 52: Pediatric Cancers

PURCHASE THE TEXTBOOK

• Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: Clinical Updates from ESMO IO Congress 2018
• Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: Clinical Updates from SITC 2018
• Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress 2018 Clinical Trials
• Advances in Cancer Immunotherapy™ Webinar Series: Updates from the Field - Highlights from AACR
• SITC Cancer Immunotherapy Guidelines - Non-Small Cell Lung Cancer (NSCLC) Recorded Webinar
• SITC Cancer Immunotherapy Guidelines - Cutaneous Melanoma 2.0 Recorded Webinar
• SITC Cancer Immunotherapy Guidelines - Renal Cell Carcinoma Recorded Webinar
• SITC Cancer Immunotherapy Guidelines - Squamous Cell Carcinoma of the Head and Neck (HNSCC)

EXPLORE ALL ONLINE OFFERINGS